Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Morbidity and Mortality After Liver Resection for Benign and Malignant Hepatobiliary Lesions
Link ID 14916
Title Morbidity and Mortality After Liver Resection for Benign and Malignant Hepatobiliary Lesions
Url http://www.medscape.com/viewarticle/589048?src=rss
Description Although most partial liver resections are performed for malignant lesions, an increasing contingent of benign lesions is also considered for surgery.
Liver International
Category Articles > Gastroenterology
Keywords
Date Apr 8, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Gastroenterology
1. HbsAg Plus HBV DNA Help Distinguish Active From Inactive Carriers
  Measuring hepatitis B virus (HBV) DNA and surface antigen (HBsAg) levels can quickly distinguish active and inactive carriers of hepatitis B virus (HBV) genotype D, new research from Italy shows. Reuters Health Information
Category:   Articles > Gastroenterology


2. Bleeding Complication With Liver Biopsy: Is it Predictable?
  How often does bleeding occur with liver biopsies, and how can it be prevented? Clinical Gastroenterology and Hepatology
Category:   Articles > Gastroenterology


3. Gene Expression and Proteomics Technologies Used for Development of Prognostic Biomarkers in Liver D
  Zobair M. Younossi, MD, explores the latest in translational research in the setting of liver disease, as based on data presented at AASLD 2007.
Medscape Gastroenterology
Category:   Articles > Gastroenterology


4. Gastroesophageal Reflux and Insomnia
  Sleep-related GER disrupts sleep, causes insomnia, and is associated with daytime functional impairment. AccessMedicine from McGraw-Hill
Category:   Articles > Gastroenterology


5. HCV Relapse Rates May Be Lower With Peginterferon Alfa-2b Than Alfa-2a
  Results of the IDEAL study reported here this week show that virologic response is equally strong with peginterferon alfa-2a or peginterferon alfa-2b in the treatment of hepatitis C virus (HCV) infection, but viral load reductions are more rapid with peginterferon alfa-2b. Reuters Health Information
Category:   Articles > Gastroenterology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS